Dr. Erin Ashton Salinas, MD

Dr. Salinas practices at Compass Oncology in Portland, Oregon.

Dr. Salinas' NPI, 1245551845, was assigned on June 17, 2010. Dr. Salinas holds Oregon license MD18196.

Dr. Salinas' primary practice is Compass Oncology, at 265 N Broadway, Portland, OR 97227 in Multnomah County. The practice phone is (360) 597-1300.

Dr. Salinas' primary practice is Compass Oncology in Portland, Oregon. Dr. Salinas is also affiliated with Providence Portland Medical Center. The medical group on file is Compass Oncology. Dmand AI also links Dr. Salinas to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salinas practices, 5 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Salinas' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Salinas' licenses on file in 2 states: Oregon and Iowa.

CMS data shows 23,951 Medicare services from Dr. Salinas across 35 procedure codes in 2024, for 213 Medicare patients. Medicare paid $102,248 for them.

CMS counts 213 Medicare patients who saw Dr. Salinas in 2024. The largest group is 65 to 74, with 123 patients. 63% of them have high blood pressure, and 60% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salinas' median patient age at 66, with 93% women.

In 2024, Dr. Salinas wrote 553 Medicare Part D claims for 122 patients. 71% of them were for generic drugs. CMS names the drug for 378 of them, across 12 drugs with 11 or more claims each, at $1,379,088 in total drug cost. In 2023, CMS named 340 claims across 16 drugs.

Dr. Salinas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salinas as offering telehealth. CMS counts 13 procedures of removal of the uterus by Dr. Salinas, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Salinas, published from 2016 to 2019. 2019 was the busiest year, with 4. The most frequent topics are Endometrial Neoplasms, Databases, Genetic and Gene Expression Regulation, Neoplastic. Dr. Salinas has published most often in Int J Mol Sci. Dr. Salinas' most frequent co-authors are Michael J. Goodheart, MD, Kimberly Kay Leslie, MD and Andreea Mihai Newtson, MD.

Dmand AI links Dr. Salinas to 9 clinical trials, 5 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Ovarian Neoplasms, Ovarian Diseases and Fallopian Tube Diseases. AbbVie sponsors the most, 2.

CMS Open Payments shows 44 general payments to Dr. Salinas from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 68% of the total. Intuitive Surgical, Inc. paid the most, $1,457.